Clinical Trial Update: A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the pharmacodynamic effects of single-dose co-administration of LX4211 (sotagliflozin) with Januvia (sitagliptin) in adults with Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• LX4211 (LX4211)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED